Clinical Trial

Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study will use 18F-FAPI PET/CT to study myocardial fibrosis in patients diagnosed with myocardial infarction-associated ventricular aneurysm (MI-VA). Participants will receive the PET/CT scan during hospital stay, as well as serial echocardiography and telephonic follow-ups. Analysed will focus on the characterization of myocardial fibrosis and its correlations with the clinical prognosis in the patients.
Trial Details
NCT Number NCT06994221
Lead Sponsor RenJi Hospital
Conditions Acute Myocardial Infarction, Ventricular Aneurysm Following Acute Myocardial Infarction, Myocardial Fibrosis
Enrollment 20 participants
Start Date 2024-11-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-29